IL33 and neoplasm: Furthermore, IL-33 EO, unlike IL-5 EO, interfered with tumor 3D-spheroid formation in vitro (Figure S2) and slowed tumor outgrowth in vivo when co-injected with B16 melanoma cells into syngeneic mice (Figure 2F).